Recall that the EZH2+CD8+ T cell population highly associates with the enhanced anti-tumor response, miR-101 and miR-26a inhibit the expression of EZH2 in CD8+ T cells (Zhao et al., 2016). This evidence concerns the gene EZH2 and neoplasm.